Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 355


Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging.

Doré-Savard L, Barrière DA, Midavaine É, Bélanger D, Beaudet N, Tremblay L, Beaudoin JF, Turcotte EE, Lecomte R, Lepage M, Sarret P.

J Nucl Med. 2013 Jun;54(6):944-52. doi: 10.2967/jnumed.112.114215. Epub 2013 Apr 17.


Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.

Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.

J Nucl Med. 2014 Feb;55(2):191-7. doi: 10.2967/jnumed.113.123646. Epub 2013 Dec 5.


(18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.

Kang WJ, Song EH, Park JY, Park YJ, Cho A, Song HT.

Nucl Med Biol. 2015 Sep;42(9):728-33. doi: 10.1016/j.nucmedbio.2015.05.003. Epub 2015 May 27.


Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause.

Rauscher I, Beer AJ, Schaeffeler C, Souvatzoglou M, Crönlein M, Kirchhoff C, Sandmann G, Fürst S, Kilger R, Herz M, Ziegler S, Schwaiger M, Eiber M.

J Nucl Med. 2015 Mar;56(3):430-5. doi: 10.2967/jnumed.114.150532. Epub 2015 Feb 12.


Evaluation of Dixon Sequence on Hybrid PET/MR Compared with Contrast-Enhanced PET/CT for PET-Positive Lesions.

Jeong JH, Cho IH, Kong EJ, Chun KA.

Nucl Med Mol Imaging. 2014 Mar;48(1):26-32. doi: 10.1007/s13139-013-0240-6. Epub 2013 Oct 15.


Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.

Varoquaux A, Rager O, Poncet A, Delattre BM, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H, Becker M.

Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):462-75. doi: 10.1007/s00259-013-2580-y. Epub 2013 Oct 10.


Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study.

Nensa F, Tezgah E, Poeppel TD, Jensen CJ, Schelhorn J, Köhler J, Heusch P, Bruder O, Schlosser T, Nassenstein K.

J Nucl Med. 2015 Feb;56(2):255-60. doi: 10.2967/jnumed.114.147744. Epub 2014 Dec 31.


Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.

Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, Weber WA.

J Nucl Med. 2008 Jul;49(7):1038-46. doi: 10.2967/jnumed.107.050187. Epub 2008 Jun 13.


Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentation.

Bagci U, Kramer-Marek G, Mollura DJ.

EJNMMI Res. 2013 Jul 5;3(1):49. doi: 10.1186/2191-219X-3-49.


Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.

Nuñez R, Macapinlac HA, Yeung HW, Akhurst T, Cai S, Osman I, Gonen M, Riedel E, Scher HI, Larson SM.

J Nucl Med. 2002 Jan;43(1):46-55.


Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.

Lin C, Bradshaw T, Perk T, Harmon S, Eickhoff J, Jallow N, Choyke PL, Dahut WL, Larson S, Humm JL, Perlman S, Apolo AB, Morris MJ, Liu G, Jeraj R.

J Nucl Med. 2016 Dec;57(12):1872-1879. Epub 2016 Jul 21.


Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT.

Heusch P, Buchbender C, Köhler J, Nensa F, Gauler T, Gomez B, Reis H, Stamatis G, Kühl H, Hartung V, Heusner TA.

J Nucl Med. 2014 Mar;55(3):373-8. doi: 10.2967/jnumed.113.129825. Epub 2014 Feb 6.


PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.

Rauscher I, Eiber M, Fürst S, Souvatzoglou M, Nekolla SG, Ziegler SI, Rummeny EJ, Schwaiger M, Beer AJ.

J Nucl Med. 2014 May;55(5):724-9. doi: 10.2967/jnumed.113.129247. Epub 2014 Mar 20.


F-18 fluoride uptake in primary breast cancer.

Sarikaya I, Sharma P, Sarikaya A.

Ann Nucl Med. 2018 Dec;32(10):678-686. doi: 10.1007/s12149-018-1294-4. Epub 2018 Sep 3.


Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.

Iagaru A, Young P, Mittra E, Dick DW, Herfkens R, Gambhir SS.

Clin Nucl Med. 2013 Jul;38(7):e290-6. doi: 10.1097/RLU.0b013e3182815f64.


18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.

Sharma P, Karunanithi S, Chakraborty PS, Kumar R, Seth A, Julka PK, Bal C, Kumar R.

Nucl Med Commun. 2014 Dec;35(12):1247-53. doi: 10.1097/MNM.0000000000000195.


Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.

Simoncic U, Perlman S, Liu G, Jeraj R.

Nucl Med Commun. 2015 Dec;36(12):1174-80. doi: 10.1097/MNM.0000000000000383.


Simultaneous PET/MR body imaging in rats: initial experiences with an integrated PET/MRI scanner.

Tatsumi M, Yamamoto S, Imaizumi M, Watabe T, Kanai Y, Aoki M, Kato H, Shimosegawa E, Hatazawa J.

Ann Nucl Med. 2012 Jun;26(5):444-9. doi: 10.1007/s12149-012-0581-8. Epub 2012 Feb 23.


Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.

Schwenzer NF, Schmidt H, Gatidis S, Brendle C, Müller M, Königsrainer I, Claussen CD, Pfannenberg AC, Schraml C.

J Magn Reson Imaging. 2014 Nov;40(5):1121-8. doi: 10.1002/jmri.24497. Epub 2013 Nov 8.


Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions.

Capitanio S, Bongioanni F, Piccardo A, Campus C, Gonella R, Tixi L, Naseri M, Pennone M, Altrinetti V, Buschiazzo A, Bossert I, Fiz F, Bruno A, DeCensi A, Sambuceti G, Morbelli S.

World J Radiol. 2016 Feb 28;8(2):200-9. doi: 10.4329/wjr.v8.i2.200.

Supplemental Content

Support Center